Varde Partners trims Nabors Industries (NBR) stake by $12.8 million

Varde Partners, a 10% owner of Nabors Industries (NBR), sold 312,378 common shares for approximately $12.8 million on September 11, 2025, while retaining a significant stake. This divestment follows NBR's Q2 2025 financial results, which significantly missed analyst expectations with an EPS of -$2.71 against an anticipated -$0.82 and slightly lower revenue, highlighting potential challenges given the company's high debt-to-equity ratio of 8.72 and noted stock volatility.

Analysis

A significant insider sale at Nabors Industries (NBR) by Varde Partners, a ten-percent owner, coincides with a period of operational underperformance, creating a bearish signal for the stock. Varde's sale of 312,378 shares for approximately $12.8 million follows NBR's Q2 2025 results, which severely missed expectations with an EPS of -$2.71 against a forecast of -$0.82 and a slight revenue miss. This poor performance is amplified by the company's highly leveraged balance sheet, evidenced by a substantial debt-to-equity ratio of 8.72. While NBR maintains a healthy current ratio of 1.79, indicating sufficient short-term liquidity, and Varde has retained a large stake, the combination of a major earnings miss, insider selling, and noted stock volatility suggests heightened risk. The absence of recent analyst rating changes indicates the market may be awaiting further clarity on how management intends to address these financial shortfalls.

Key Decisions for Investors

• Investors should treat the insider sale by a 10% owner as a significant cautionary signal, especially given its timing immediately following a major earnings miss.
• The high debt-to-equity ratio of 8.72 represents a critical risk factor; any further deterioration in earnings could place significant strain on the company's financial stability.
• Given the stock's high volatility and the current uncertainty, it is prudent to monitor for management's strategic response to the performance shortfall and any subsequent analyst ratings revisions before adjusting positions.